How do we help breast cancer patients?

We review your case and provide a list of options from available breast cancer clinical trials close to your home as part of Massive Bio SYNERGY-AI program or Massive Bio Virtual Tumor Board solution.

We can provide a second opinion through our Virtual Tumor Board from a breast cancer specialist. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.

Clinical Trials

There are approximately 958 breast cancer clinical trials that are currently recruiting patients in the United States right now. With such an extensive list, many of them could be beneficial for you. Our team of oncology nurses and our artificial intelligence based clinical trial matching system will find the best option for you.

A Study of TAS-120 in Patients With Metastatic Breast Cancer.

Breast Cancer Facts

Breast cancer is the second most common cancer type for women. 12.8% of women will be diagnosed with breast cancer throughout their life. Even though most people think of women when it comes to breast cancer, roughly 1% of breast cancer patients are male. Over 268,000 new cases last year alone. 67% of breast cancer patients have the subtype HR+/HER2, which makes it the most common by far considering the next most common subtype being HR-/HER2, which includes about 10% of the breast cancer population.


The breast cancer cells typically begin growing in the milk-producing ducts. Family history does play a role in breast cancer through gene mutations. Radiation exposure, obesity, and never being pregnant have all been linked to increasing one’s chance at getting breast cancer. Women represent roughly 99% of the breast cancer population, so being female is also an inherent risk factor.


The common treatment methods for breast cancer patients include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, immunotherapy. Oncologists determine the appropriate method of treatment based on the stage and genetic mutations of the breast cancer.

Learn Your Breast Cancer Clinical Trial and Treatment Options

By submitting, you agree to our Terms And Conditions and have read and acknowledged our Privacy Statement.


By far the most common type of screening is a mammogram. For those who have a family history or at a high risk of breast cancer, MRI’s are also used. Other screening methods that are currently being utilized within clinical trials are breast exams, thermography, and tissue sampling.


The number of cases of breast cancer have increased slightly since 1975. The number of cases went from 105 per 100,000 to 129 per 100,000 in 2016. Even though the amount of breast cancer patients have increased, the amount of deaths have decreased steadily from 31 to 20 per 100,000. This means progress has been made in the overall treatment of breast cancer, but not in the prevention of it.


  • Luminal A
  • Luminal B
  • Triple negative/basal-like
  • HER2-enriched


Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.